206(top 1%)
papers
11.3K(top 1%)
citations
53(top 1%)
h-index
104(top 1%)
g-index
216
all documents
12.2K
doc citations
2.0K
citing journals

Top Articles

#TitleJournalYearCitations
1JNK signaling in apoptosisOncogene20081,259
2Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasiaNature Genetics1999711
3Modulation of life and death by the TNF receptor superfamilyOncogene1998497
4TAMeless traitors: macrophages in cancer progression and metastasisBritish Journal of Cancer2017471
5The myb gene family in cell growth, differentiation and apoptosisOncogene1999456
6Janus kinases: components of multiple signaling pathwaysOncogene2000423
7Liver stem cells and hepatocellular carcinomaHepatology2009291
8Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 studyLancet Oncology, The2015249
9Hematopoietic cytokine receptor signalingOncogene2007233
10Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma.Proceedings of the National Academy of Sciences of the United States of America1989226
11T Cell Dysfunction and Exhaustion in CancerFrontiers in Cell and Developmental Biology2020226
12PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro.Proceedings of the National Academy of Sciences of the United States of America1994220
13Arrest of spermatogenesis and defective breast development in mice lacking A-mybNature1997213
14IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiledOncogene2000205
15Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domainOncogene1993204
16Activation of Jun Kinase/Stress-activated Protein Kinase by GTPase-deficient Mutants of Gα12 and Gα13Journal of Biological Chemistry1995168
17Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialLancet Oncology, The2017148
18Clinical and translational advances in esophageal squamous cell carcinomaAdvances in Cancer Research2019140
19Regulation of cell proliferation by G proteinsOncogene1998137
20JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factorsProceedings of the National Academy of Sciences of the United States of America2002137
21The promise of epigenetic therapy: reprogramming the cancer epigenomeCurrent Opinion in Genetics and Development2017136
22Activation of p38α/β MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein CdoJournal of Cell Biology2006117
23Gadd45 Stress Sensors in Malignancy and LeukemiaCritical Reviews in Oncogenesis2011117
24Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activationOncogene2007113
25The Interferon-Gamma Paradox in CancerJournal of Interferon and Cytokine Research2019112
26TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast CancerCancer Research2018109
27Phosphorylation of Atg5 by the Gadd45β–MEKK4-p38 pathway inhibits autophagyCell Death and Differentiation2013107
28Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced TumorigenesisCancer Cell2019107
29Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cellsBlood2013105
30Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell propertiesScientific Reports2013104
31Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunityNature Communications201799
32Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient.Proceedings of the National Academy of Sciences of the United States of America198998
33Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4Cancer Research201896
34Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant miceOncogene200395
35TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor–Binding Sites in Chronic Myelomonocytic LeukemiaCancer Research201580
36Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidatesScience Advances202180
37Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune SuppressionCancer Research201977
38Age-related epigenetic drift in the pathogenesis of MDS and AMLGenome Research201476
39Epigenetic changes and assisted reproductive technologiesEpigenetics202075
40Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transitionGenome Biology201374
41Epigenetics and Precision OncologyCancer Journal (Sudbury, Mass )201773
42Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trialLancet Haematology,the201971
43Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiationOncogene200070
44AATYK: A novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cellsOncogene199768
45Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signallingNature Cell Biology202067
46Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root GanglionJournal of Neuroscience201866
47Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasisNature Communications202065
48Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasmsBlood201764
49Genetically engineered mouse models of melanomaCancer201762
50Differentiation primary response genes and proto‐oncogenes as positive and negative regulators of terminal hematopoietic cell differentiationStem Cells199461